Toggle navigation
Home
Search
Services
Blog
Contact
About
Galloway, Gantt P.
Search 19 grants from Gantt Galloway
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
HIV-1 Vpr disrupts the IFN-TET-ISG pathway to promote HIV-1 infection and persistence
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
Genomic Basis of Premature Ovarian Insufficiency
Spina Bifida Patient Registry Demonstration Project
PS1 and PS2 Regulate Proteolytic Cleavage of App
Recently added grants:
2/3 Lay-delivered Behavioral Activation in Senior Centers
Small non-coding RNAs of VZV: role in lytic and latent infection
Dissecting Neural Circuits Involved in Musculoskeletal Pain
Investigation of the molecular mechanisms of vascular endothelial dysfunction in Hutchinson-Gilford Progeria Syndrome through in vitro 2D and 3D models
Investigating the molecular requirements for ESX-1-lytic activity in pathogenic mycobacteria
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research and Development Contracts (N01)
Project #
N01DA78863-4-0-0
Application #
7543132
Study Section
Project Start
2007-04-23
Project End
2012-04-22
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 DA
Medications Development for Stimulant Dependence
Galloway, Gantt P. / California Pacific Medical Center Research Institute
$1,138,487
NIH 2007
N01 DA
Galloway, Gantt P. /
NIH 2007
N01 DA
Medications Development for Stimulant Dependence
/
Comments
Be the first to comment on Gantt Galloway's grant